200 70980 advanced:3.55891312765391 reason:3.55891312765391 cancer:4.63203032133495 case:0.325148690291958 cohort:2.32203570971108 investigators:1.68711095075232 control:0.919855798038651 design:2.29943659920322 draw:1.80971327284465 eric:4.53974238066564 figure:1.80971327284465 men:2.38025813131226 follow:2.04646830498498 men:2.38025813131226 gonna:3.55891312765391 health:2.6957904563707 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 levels:1.07400647786591 lorelei:4.53974238066564 1986:4.08506565095307 mucci:4.25206030821386 nested:2.93030446823154 professionals:6.88226018399506 prostate:7.69319040021138 invited:2.74798291143758 interesting:0.834333624600489 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 toenails:2.54731221597543 started:1.49601108222398 study:2.66418375632041 talk:0.84683782344952 thought:3.84956520525888 thought:8.0578335137993 undertook:4.53974238066564 men:0.485063074835967
70980 151840 1987:3.24045939653538 author:0.489454245962768 beginning:1.51122028428865 biological:3.24045939653538 population:0.325148690291958 back:7.69319040021138 clipping:4.02891675689965 1996:1.68711095075232 nested:0.919855798038651 control:9.8904149775476 end:0.802072762382268 entire:1.94947521521981 factors:0.90215622093925 health:1.02323415249249 study:4.9452074887738 grow:3.15344801954575 happened:0.60791674794131 37000:1.34789522818535 giovannucci:3.80672045060016 hypothesis:9.8904149775476 levels:1.07400647786591 toenails:2.74798291143758 hypothesis:0.396607654274103 50000:1.36168855031769 nail:8.50412061642772 source:2.93030446823154 part:1.0844777777332 study:0.514390689930487 previous:0.867670044868081 man:3.44113009199753 study:2.38025813131226 larry:1.17244655067916 study:1.38985942728439 reflect:1.49521994294221 back:3.84659520010569 follow:2.54731221597543 specimens:3.69244452027843 1996:2.99929733971849 study:2.07214292158254 takes:1.71846235244443 toenail:16.1156670275986 clark:1.54401010711165 study:0.956223442209526 year:0.970126149671934
151840 223500 study:7.11782625530782 follow:1.28164584264415 basically:4.63203032133495 nested:1.62574345145979 case:3.6794231921546 case:0.87618073453599 study:4.9452074887738 ed:0.802072762382268 1996:1.02323415249249 funds:3.84659520010569 study:1.34789522818535 study:1.83169217956343 levels:1.07400647786591 limited:1.66806275578162 set:0.810040932031445 controls:0.526366880977203 measure:0.396607654274103 37000:4.08506565095307 undertook:8.79091340469462 risk:0.153557735843091 prostate:1.57791165878733 cases:1.78820706762369 risk:3.44113009199753 1994:11.5397856003171 sampling:0.417998844255421 advanced:2.45789659394988 cancer:1.33708273951549 undertook:2.89739985461464 selenium:3.84659520010569 prostate:1.12699344128658 study:1.48010208684467 looked:0.0700101655726489 men:9.07948476133128
223500 284230 develop:7.11782625530782 controls:0.550758334101362 cancer:4.63203032133495 follow:0.325148690291958 clark:3.84659520010569 compare:1.26881672677657 cancer:0.919855798038651 men:1.75236146907198 epidemiological:2.41947884446554 find:0.778542264972074 follow:3.06970245747747 found:3.5343073168517 health:1.34789522818535 men:3.15344801954575 larry:4.9452074887738 selenium:3.22201943359773 toenails:1.47947158597407 compared:3.44113009199753 toenails:0.793215308548206 melanoma:4.53974238066564 men:6.80844275158845 follow:0.153557735843091 calculate:0.984394319176222 population:0.514390689930487 professionals:3.44113009199753 advanced:7.69319040021138 randomized:1.17244655067916 odds:0.654748047625409 measure:2.34251780332942 researchers:1.94947521521981 results:0.634408363388287 relative:1.22894829697494 measured:7.69319040021138 skin:3.69244452027843 source:2.54731221597543 specimen:3.69244452027843 study:0.888061252106805 toenail:16.1156670275986 trial:1.54401010711165 toenails:0.970126149671934
284230 352510 question:2.14184710786727 case:3.55891312765391 authors:3.24045939653538 address:0.550758334101362 prostate:1.54401010711165 case:0.975446070875874 chance:1.14971829960161 cohort:2.32203570971108 bit:2.4603008389858 conducted:2.54731221597543 control:1.8397115960773 critiquing:3.44113009199753 risk:1.68711095075232 sampling:1.14971829960161 detail:2.11199414471758 question:1.9747930232041 estimate:0.748005541111992 researchers:1.83169217956343 line:0.984394319176222 cohort:2.69391569016731 nested:2.93030446823154 paper:1.7263316639056 source:0.514390689930487 complex:2.80514132527753 advanced:3.84659520010569 questions:2.60180428458495 randomized:1.17244655067916 read:1.52748080516043 relative:2.34251780332942 design:1.94947521521981 results:0.634408363388287 risk:2.45789659394988 set:2.00562410927323 risk:0.75132896085772 control:2.54731221597543 study:0.888061252106805 talk:0.42341891172476 thinking:1.83169217956343 trial:1.54401010711165
352510 417890 advanced:3.55891312765391 cancer:3.0880202142233 potential:0.650297380583916 exposure:2.59383223161032 categorize:2.59383223161032 case:1.49521994294221 set:1.8397115960773 diagnosed:6.67225102312648 1993:5.73153189418792 relates:3.88364774244018 question:0.793215308548206 control:0.153557735843091 study:9.8904149775476 participant:7.69913041051776 question:0.582108863985438 risk:2.95894317194814 prostate:7.69319040021138 diagnosed:2.60180428458495 1990:1.28164584264415 exclude:0.614474148487469 question:3.84659520010569 participant:0.37566448042886 things:2.59383223161032 measurement:0.296020417368935 selenium:0.209009040379305 exposure:4.25206030821386
417890 485290 years:1.70652903660942 concerned:5.9243790696123 limitations:2.64262239577975 core:1.92478260262944 finally:2.08300660784433 exposure:4.25206030821386 divided:0.725699783597694 concepts:1.43366204994278 equal:0.462204936759917 risk:0.748005541111992 exposure:3.88364774244018 exposure:2.4390281230743 study:0.778542264972074 estimate:3.55891312765391 influence:2.34251780332942 groups:0.249282939517245 happened:0.60791674794131 recently:5.84842564565943 influence:1.52748080516043 levels:1.07400647786591 potential:1.66806275578162 measurement:1.18982296282231 findings:2.95894317194814 bias:1.04072171383398 quintiles:4.53974238066564 reflect:3.07340531187221 reflect:2.99043988588442 influence:2.34251780332942 epidemiology:2.5632916852883 relative:0.614474148487469 selenium:7.69319040021138 study:0.888061252106805 relates:3.07340531187221 study:4.53974238066564 window:2.38025813131226 20:0.485063074835967
485290 555620 cancer:3.55891312765391 chemo:2.93030446823154 cancer:1.70652903660942 secondary:1.14971829960161 found:1.11656609228471 undertaken:1.00362568110411 studies:3.55891312765391 selenium:1.40424816473649 risk:9.2640606426699 selenium:4.9452074887738 clark:3.84659520010569 compare:1.26881672677657 epidemiological:2.54731221597543 contrast:3.3357695763397 based:0.231182897873627 randomized:4.83895768893108 1996:3.5343073168517 national:3.3357695763397 blood:2.99929733971849 larry:4.9452074887738 association:1.07400647786591 selenium:1.47947158597407 analysis:2.72337710063538 years:2.4603008389858 men:2.5028604534046 thinking:1.47947158597407 potential:5.18766446322064 prostate:2.38025813131226 lower:19.2329760005284 published:2.38025813131226 randomized:3.51733965203748 60:1.84342244546241 found:4.02891675689965 undertook:2.89739985461464 randomized:19.2329760005284 trail:1.29454924748006 study:1.48010208684467 prostate:1.83169217956343 biomarkers:4.02891675689965 trial:4.9452074887738 study:1.54401010711165 study:9.07948476133128 cancer:4.53974238066564 prostate:0.485063074835967
555620 623410 guess:2.02743675668952 found:1.11656609228471 placebo:2.1689555554664 randomized:0.281768394661733 healthy:4.63203032133495 larry:3.84659520010569 trial:0.634408363388287 years:3.3357695763397 disadvantages:0.919855798038651 factorial:1.14971829960161 time:2.64262239577975 question:2.99929733971849 evidence:0.96552583487184 contrast:4.83895768893108 104:1.87715455364018 called:3.44113009199753 published:1.02323415249249 study:3.5343073168517 prostate:2.64262239577975 states:2.64262239577975 results:4.9452074887738 35000:1.36168855031769 vitamin:2.5028604534046 selenium:2.59383223161032 risk:7.69319040021138 found:3.07340531187221 study:2.38025813131226 cancer:1.04072171383398 diagnosis:3.51733965203748 design:1.87715455364018 recruited:3.07340531187221 cancer:2.34251780332942 studies:0.634408363388287 selenium:1.22894829697494 received:15.3863808004228 united:1.41884696415764 average:1.48010208684467 effect:3.69244452027843 cancer:0.0700101655726489 randomized:1.54401010711165 men:1.70652903660942 selenium:5.99859467943698 study:0.485063074835967
623410 654100 answers:0.538488241509547 bias:1.9747930232041 comments:2.86576594709396 comparison:1.9747930232041 concerned:2.08300660784433 confounding:1.36168855031769 controlled:0.919855798038651 critique:6.88226018399506 epidemiological:2.41947884446554 explanations:2.38025813131226 exposure:1.29454924748006 final:1.21951406153715 forward:2.30615015915854 interpretation:1.52748080516043 letting:3.24045939653538 logging:2.34251780332942 outcomes:0.654748047625409 part:1.0844777777332 plausible:3.44113009199753 post:2.86576594709396 providing:2.05483573087764 question:1.04072171383398 randomized:1.17244655067916 study:0.888061252106805 thoughts:1.92478260262944
